180 Life Sciences appoints Jay Goodman to Board, pivots to online gaming

FORUM MARKETS Inc

Jay Goodman appointed as Class I director effective Oct 24, 2024; compensation $50k/yr + $15k as Comp Committee Chair.
Blair Jordan's director offer letter terminated as he serves as Interim CEO; continues under consulting agreement.
Goodman is son of Anthony Goodman (CEO of Elray Resources), which holds convertible preferred stock representing 40% of common.
Company expanding into online gaming market; cites Goodman's experience in SaaS and iGaming as instrumental.
Goodman has over 10 yrs in SaaS, 6+ yrs in iGaming, roles at Docker, Confluent, Skywind.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jay Goodman

Director

FRMM · FORUM MARKETS Inc

Effective: 2024-10-24
Filed: October 29, 2024, 7:59 PM ET

Effective October 24, 2024, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) appointed Jay Goodman (the “ Appointee ” and the “ Appointment ”) as a member of the Board of Directors (“ Board ”), which Appointment was effective as of the same date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jay Goodman was appointed as Director at FORUM MARKETS Inc.

Action: appointed
Role: Director

Exact text from the filing

Effective October 24, 2024, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) appointed Jay Goodman (the “ Appointee ” and the “ Appointment ”) as a member of the Board of Directors (“ Board ”), which Appointment was effective as of the same date.

View on SEC.gov

FORUM MARKETS Inc filing history →

Source: SEC EDGAR

accession 0001213900-24-091422

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.